Literature DB >> 12034446

A kinetic trap is an intrinsic feature in the folding pathway of single-chain Fv fragments.

Wolfgang Hoyer1, Kathrin Ramm, Andreas Plückthun.   

Abstract

We have studied the equilibrium unfolding and the kinetics of folding and unfolding of an antibody scFv fragment devoid of cis-prolines. An anti-GCN4 scFv fragment carrying a VL lambda domain, obtained by ribosome display, served as the model system together with an engineered destabilized mutant in VH carrying the R66K exchange. Kinetic and equilibrium unfolding experiments indicate that the VH mutation also affects VL unfolding, possibly by partially destabilizing the interface provided by VH, even though the mutation is distant from the interface. Upon folding of the scFv fragment, a kinetic trap is populated whose escape rate is much faster with the more stable VH domain. The formation of the trap can be avoided if refolding is carried out stepwise, with VH folding first. These results show that antibody scFv fragments do not fold by the much faster independent domain folding, but instead form a kinetically trapped off-pathway intermediate, which slows down folding under native conditions. This intermediate is characterized by premature interaction of the unfolded domains, and particularly involving unfolded VH, independent of proline cis-trans isomerization in VL. This work also implies that VH should be a prime target in engineering well behaving antibody fragments.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12034446     DOI: 10.1016/s0301-4622(02)00022-4

Source DB:  PubMed          Journal:  Biophys Chem        ISSN: 0301-4622            Impact factor:   2.352


  8 in total

Review 1.  The use of single chain Fv as targeting agents for immunoliposomes: an update on immunoliposomal drugs for cancer treatment.

Authors:  W W Cheng; T M Allen
Journal:  Expert Opin Drug Deliv       Date:  2010-04       Impact factor: 6.648

2.  A scFv antibody mutant isolated in a genetic screen for improved export via the twin arginine transporter pathway exhibits faster folding.

Authors:  Brian Ribnicky; Thomas Van Blarcom; George Georgiou
Journal:  J Mol Biol       Date:  2007-03-31       Impact factor: 5.469

3.  Functional expression of a single-chain antibody fragment against human epidermal growth factor receptor 2 (HER2) in Escherichia coli.

Authors:  Vajihe Akbari; Hamid Mir Mohammad Sadeghi; Abbas Jafrian-Dehkordi; Daryoush Abedi; C Perry Chou
Journal:  J Ind Microbiol Biotechnol       Date:  2014-03-27       Impact factor: 3.346

4.  Rapid folding and unfolding of Apaf-1 CARD.

Authors:  Sara L Milam; Nathan I Nicely; Brett Feeney; Carla Mattos; A Clay Clark
Journal:  J Mol Biol       Date:  2007-03-15       Impact factor: 5.469

5.  The Skp chaperone helps fold soluble proteins in vitro by inhibiting aggregation.

Authors:  Kevin C Entzminger; Christine Chang; Ryan O Myhre; Katie C McCallum; Jennifer A Maynard
Journal:  Biochemistry       Date:  2012-06-08       Impact factor: 3.162

6.  Increased Fab thermoresistance via VH-targeted directed evolution.

Authors:  Kevin C Entzminger; Jennifer L Johnson; Jeongmin Hyun; Raquel L Lieberman; Jennifer A Maynard
Journal:  Protein Eng Des Sel       Date:  2015-08-16       Impact factor: 1.650

7.  Kinetic traps in the folding/unfolding of procaspase-1 CARD domain.

Authors:  Yun-Ru Chen; A Clay Clark
Journal:  Protein Sci       Date:  2004-08       Impact factor: 6.725

8.  Structural features of T cell receptor variable regions that enhance domain stability and enable expression as single-chain ValphaVbeta fragments.

Authors:  Sarah A Richman; David H Aggen; Michelle L Dossett; David L Donermeyer; Paul M Allen; Philip D Greenberg; David M Kranz
Journal:  Mol Immunol       Date:  2008-10-29       Impact factor: 4.407

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.